Tag: Sun Pharma Ltd. has declared the results of Q2 FY16
Company has posted not good results. On the consolidated basis, for the current quarter ended September 30, 2015 company has reported 41.1% decline & 14.7% rise in net profit and 46% decline & 11.5% rise (ex. Exceptional items) in Profit after tax as compared to for the same quarter in the previous year ended September 30, 2014 and for previous quarter ended June 30, 2015. Net Revenues of the company has decreased by 14.7% on Y-O-y basis and increased marginally by 4.3% on Q-o-Q basis.
Company had incurred exceptional losses of 685 cr. in previous quarter ended June 30, 2015. Exceptional expenses are not ordinary expenses and occur rarely and have no impact in future earnings. So we have filtered those effects. Latest Key Indicators of the stock are as follows:<br /><a class="btn btn-tislider-two" href="http://www.ifminvest.in/sun-pharma-ltd-has-declared-the-results-of-q2-fy16/">Read More</a>